Novel (4-Piperidin-1-yl)-phenyl Sulfonamides as Potent and Selective Human β3 Agonists

Add time:07/15/2019    Source:sciencedirect.com

A series of novel (4-piperidin-1-yl)-phenyl sulfonamides was prepared and evaluated for their biological activity on the human β3-adrenergic receptor (AR). Replacement of the 3,4-dihydroxyl group of the catechol moiety with 4-hydroxyl-3-methyl sulfonamide on the left-hand side of the compounds resulted in a number of potent full agonists at the β3 receptor. Modification of the right-hand side of the compounds by incorporation of a free carboxylic acid resulted in a few potent human β3 agonists with low affinities for β1- and β2-ARs. N-Alkyl substitution on the 4-piperidin-1-yl-phenylamine further increased the β3 potency while maintaining the selectivity. For example, sulfonamide 48 is a potent full β3 agonist (EC50=0.004 μM, IA=1.0) with >500-fold selectivity over β1- and β2-ARs.

We also recommend Trading Suppliers and Manufacturers of N-[4-(benzyloxy)phenyl]-N-phenylamine (cas 60709-95-7). Pls Click Website Link as below: cas 60709-95-7 suppliers

Prev:The discovery of [1-(4-dimethylamino-benzyl)-piperidin-4-yl]-[4-(3,3-dimethylbutyl)-phenyl]-(3-methyl-but-2-enyl)-amine, an N-type Ca+2 channel blocker with oral activity for analgesia
Next:Revised kinetics of CO2 absorption in aqueous N,N-diethylethanolamine (DEEA) and its blend with N-methyl-1,3-propane-diamine (MAPA))